| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |